The Connecticut Attorney General reached an agreement with Hartford Healthcare to address antitrust concerns in the acquisition of Manchester Memorial and Rockville General hospitals from Prospect Medical. The agreement includes conditions to limit cost increases, waive physician non-compete clauses, and maintain medical staff privileges to protect competition and physician mobility. This resolves the antitrust review under the state's notice of material change statute.
The agreement requires Hartford Healthcare to limit cost increases at Manchester Memorial and Rockville General hospitals for two years, waive non-compete clauses in physician contracts to allow mobility within 90 days, maintain privileges for physicians who move to other systems, and keep an open medical staff.
In-house legal teams should review contracts involved in healthcare acquisitions to ensure they incorporate antitrust compliance measures, include provisions for cost controls such as limits on reimbursement increases, protect physician mobility by waiving or limiting non-compete clauses, and maintain medical staff access. They should also consider state-specific requirements like Connecticut's notice of material change statute and ensure ongoing reporting or compliance programs as required by such agreements.
Entity
Hartford Healthcare
Industry
HealthcareOfficial Press Release
https://portal.ct.gov/ag/press-releases/2025-press-releases/attorney-general-tong-announces-agreement-with-hartford-healthcare
20251226 hhc agreement of assurances executed.pdf?rev=ea2c8a
https://portal.ct.gov/-/media/ag/press_releases/2025/20251226-hhc-agreement-of-assurances-executed.pdf?rev=ea2c8a0bc05443228701b046de43db5c&hash=81EFFA813352E503FC2F4846B321DC74
Connecticut Attorney General Enforcement Page
https://portal.ct.gov/AG/Privacy/Privacy-Resources
"Hartford Healthcare"
"the state’s “notice of material change” statute"
"Connecticut Unfair Practices Act"
$625K
Connecticut reached a $625,000 settlement with Frontier Communications Parent Inc. over an April 2024 breach in which compromised employee and vendor credentials were used to access internal systems and exfiltrate unencrypted personal information of 58,841 Connecticut residents. The settlement requires Frontier to strengthen its security program, implement specific safeguards and training, and obtain an independent third-party assessment.
$2.6M
Connecticut and New York found that Boston Children’s Health Physicians and its security vendor, XTIUM, failed to use reasonable safeguards, resulting in hackers accessing sensitive personal, medical, and employee information. The companies agreed to pay penalties totaling $2.64 million and implement enhanced cybersecurity measures.
Connecticut joined a coalition of state attorneys general filing a notice in Character Technologies, Inc.’s bankruptcy proceedings, raising concerns about the company’s safety and privacy practices and the sensitive information it holds. The states seek protections for children and consumers if the company’s business or assets are sold or transferred; the filing does not impose a fine or other remedy.
Attorney General William Tong and Consumer Counsel Claire Coleman petitioned PURA to review how Connecticut public utilities use artificial intelligence, citing potential data privacy and cybersecurity risks, algorithmic errors, and misleading outputs. The petition asks PURA to examine utility AI systems, safeguards, vendors, and data security practices; it does not report a finding of violation or an imposed penalty.
$2.0M
Connecticut Attorney General William Tong announced a settlement with RZ Smoke, Inc. over allegations that it distributed and sold high-potency cannabis products without a state license. The stipulated judgment is $2 million, with $375,000 payable to the State and $1.6 million suspended to ensure compliance; the company is barred from specified cannabis activities in Connecticut unless licensed.
$13.7M
Connecticut joined a coalition of states and the federal government in settling allegations that Takeda paid healthcare providers speaker honoraria and provided meals to induce prescriptions of Trintellix, leading to allegedly false claims to government healthcare programs. Takeda agreed to pay $13,670,921 plus accrued interest, with portions allocated to federal and state programs.